1. Home
  2. PHVS vs BH Comparison

PHVS vs BH Comparison

Compare PHVS & BH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • BH
  • Stock Information
  • Founded
  • PHVS 2015
  • BH 1934
  • Country
  • PHVS Switzerland
  • BH United States
  • Employees
  • PHVS N/A
  • BH N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • BH Restaurants
  • Sector
  • PHVS Health Care
  • BH Consumer Discretionary
  • Exchange
  • PHVS Nasdaq
  • BH Nasdaq
  • Market Cap
  • PHVS 980.9M
  • BH 904.4M
  • IPO Year
  • PHVS 2021
  • BH N/A
  • Fundamental
  • Price
  • PHVS $22.32
  • BH $294.30
  • Analyst Decision
  • PHVS Buy
  • BH
  • Analyst Count
  • PHVS 6
  • BH 0
  • Target Price
  • PHVS $37.17
  • BH N/A
  • AVG Volume (30 Days)
  • PHVS 33.8K
  • BH 19.7K
  • Earning Date
  • PHVS 08-13-2025
  • BH 08-08-2025
  • Dividend Yield
  • PHVS N/A
  • BH N/A
  • EPS Growth
  • PHVS N/A
  • BH N/A
  • EPS
  • PHVS N/A
  • BH N/A
  • Revenue
  • PHVS N/A
  • BH $367,698,000.00
  • Revenue This Year
  • PHVS N/A
  • BH N/A
  • Revenue Next Year
  • PHVS N/A
  • BH N/A
  • P/E Ratio
  • PHVS N/A
  • BH N/A
  • Revenue Growth
  • PHVS N/A
  • BH 0.85
  • 52 Week Low
  • PHVS $11.51
  • BH $159.69
  • 52 Week High
  • PHVS $25.76
  • BH $308.62
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 73.31
  • BH 63.50
  • Support Level
  • PHVS $17.63
  • BH $282.42
  • Resistance Level
  • PHVS $19.00
  • BH $308.62
  • Average True Range (ATR)
  • PHVS 1.20
  • BH 9.09
  • MACD
  • PHVS 0.35
  • BH -0.56
  • Stochastic Oscillator
  • PHVS 92.15
  • BH 46.37

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company which is engaged in developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

About BH Biglari Holdings Inc. Class B

Biglari Holdings Inc is a holding company that owns subsidiaries in a range of businesses. The company's reportable segments include Restaurant Operations, Insurance Operations, Oil and Gas Operations. Company's restaurant operations include Steak n Shake and Western Sizzlin. Its insurance operations include First Guard, Southern Pioneer, and Biglari Reinsurance. Oil and gas operations include Southern Oil and Abraxas Petroleum. The Company also reports segment information for Maxim. The majority of revenue is derived from the Maxim Segment.

Share on Social Networks: